13 results
10-K
2020 FY
ONCR
Oncorus, Inc.
10 Mar 21
Annual report
4:12pm
review by the FDA, Department of Justice, Department of Health and Human Services’ Office of Inspector General, state attorneys general, members
424B4
ONCR
Oncorus, Inc.
12 Feb 21
Prospectus supplement with pricing info
4:23pm
Services’ Office of Inspector General, state attorneys general, members of Congress, and the public. When the FDA or comparable foreign regulatory
DRS
ONCR
Oncorus, Inc.
28 Jan 21
Draft registration statement
12:00am
, state attorneys general, members of Congress, and the public. When the FDA or comparable foreign regulatory authorities issue regulatory approval
10-Q
5mjyfhyd8c5214ekn0xe
12 Nov 20
Quarterly report
8:01am
424B4
sd53l3g89ui9 dgtiwy
2 Oct 20
Prospectus supplement with pricing info
12:00am
S-1
zmm53hpes3jp1nex
11 Sep 20
IPO registration
4:49pm
DRS/A
wztresm7wm3v 4u1r5j
26 Aug 20
Draft registration statement (amended)
12:00am
DRS/A
5hqrv1f7z0vigdz
29 Jul 20
Draft registration statement (amended)
12:00am
DRS/A
qm0 lpgbb
20 Dec 19
Draft registration statement (amended)
12:00am
DRS
o10umtbp6tpa
31 Oct 19
Draft registration statement
12:00am
- Prev
- 1
- Next